Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01383954 · ClinicalTrials.gov registry record · Phase 4
The Efficacy of Diclofenac Gel for Breakthrough Pain and the Neuropathic Components of Pain in Knee Osteoarthritis
A Phase 4 study of Knee Osteoarthritis, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT01383954 is a Phase 4 study of Knee Osteoarthritis that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 52 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01383954, a Phase 4 study of Knee Osteoarthritis, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this proposed study is to conduct a trial with knee osteoarthritis (OA) patients using the diclofenac gel.
Conditions Studied
Interventions
- DRUG Diclofenac Gel
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Chestnut Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01383954
The ClinicalTrials.gov registry entry for NCT01383954 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (83% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Diclofenac Gel is the first listed.
NCT01383954 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01383954 about?
NCT01383954 is a clinical study titled "The Efficacy of Diclofenac Gel for Breakthrough Pain and the Neuropathic Components of Pain in Knee Osteoarthritis". The purpose of this proposed study is to conduct a trial with knee osteoarthritis (OA) patients using the diclofenac gel.
What is the current status of trial NCT01383954?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 52 participants. The study started on 2011-06. Estimated completion is 2012-12.
What conditions does trial NCT01383954 study?
This clinical trial studies the following conditions: Knee Osteoarthritis.
What interventions are being tested in trial NCT01383954?
The interventions under investigation include: Diclofenac Gel (DRUG).
Who is sponsoring clinical trial NCT01383954?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01383954 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis
RECRUITING · Phase 4
-
Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty
RECRUITING · Phase 4
-
Extended Postoperative Oral Tranexamic Acid in Knee Replacement
ACTIVE NOT RECRUITING · Phase 4
-
The Effect of Intra-articular Bilateral Knee Injections of Zilretta on Performance Measures in Adults With Knee OA
COMPLETED · Phase 4
-
Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk
COMPLETED · Phase 4
-
To Look at the Characteristics of Synovial Fluid and Cartilage Matrix in Osteoarthritic Knee After Hyaluronic Acid Injection
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.